Lexicon Pharmaceuticals, Inc. (LXRX)
2.325
+0.02
(+1.09%)
USD |
NASDAQ |
Aug 24, 16:00
2.325
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Total Assets (Quarterly) : 250.06M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 250.06M |
| March 31, 2026 | 268.82M |
| December 31, 2025 | 184.99M |
| September 30, 2025 | 205.93M |
| June 30, 2025 | 225.58M |
| March 31, 2025 | 297.67M |
| December 31, 2024 | 298.42M |
| September 30, 2024 | 321.12M |
| June 30, 2024 | 373.36M |
| March 31, 2024 | 417.22M |
| December 31, 2023 | 229.43M |
| September 30, 2023 | 276.48M |
| June 30, 2023 | 316.72M |
| March 31, 2023 | 162.72M |
| December 31, 2022 | 194.30M |
| September 30, 2022 | 191.68M |
| June 30, 2022 | 112.32M |
| March 31, 2022 | 136.18M |
| December 31, 2021 | 136.91M |
| September 30, 2021 | 172.33M |
| June 30, 2021 | 171.67M |
| March 31, 2021 | 193.26M |
| December 31, 2020 | 203.79M |
| September 30, 2020 | 178.93M |
| June 30, 2020 | 322.54M |
| Date | Value |
|---|---|
| March 31, 2020 | 370.57M |
| December 31, 2019 | 421.86M |
| September 30, 2019 | 444.59M |
| June 30, 2019 | 233.14M |
| March 31, 2019 | 258.52M |
| December 31, 2018 | 288.65M |
| September 30, 2018 | 310.19M |
| June 30, 2018 | 332.94M |
| March 31, 2018 | 386.81M |
| December 31, 2017 | 441.42M |
| September 30, 2017 | 329.49M |
| June 30, 2017 | 363.51M |
| March 31, 2017 | 396.26M |
| December 31, 2016 | 944.02M |
| September 30, 2016 | 516.94M |
| June 30, 2016 | 558.13M |
| March 31, 2016 | 611.34M |
| December 31, 2015 | 1.068B |
| September 30, 2015 | 391.14M |
| June 30, 2015 | 415.96M |
| March 31, 2015 | 444.68M |
| December 31, 2014 | 883.80M |
| September 30, 2014 | 187.52M |
| June 30, 2014 | 224.06M |
| March 31, 2014 | 243.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Viatris, Inc. | 35.04B |
| Pfizer Inc. | 201.13B |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 75.54M |
| Shareholders Equity (Quarterly) | 174.52M |
| Debt to Equity Ratio | 0.3394 |
| Current Ratio | 13.37 |
| Net Debt Paydown Yield | 0.88% |